Preface
Systemic treatment of cutaneous and mucosal melanoma
Chinese Clinical Oncology
2014;
3
(3)
:25
.
(01 September 2014)
Review Article
Melanoma adjuvant therapy
Chinese Clinical Oncology
2014;
3
(3)
:26
.
(01 September 2014)
Genotyping of cutaneous melanoma
Chinese Clinical Oncology
2014;
3
(3)
:27
.
(01 September 2014)
Treatment of BRAF-mutated advanced cutaneous melanoma
Chinese Clinical Oncology
2014;
3
(3)
:28
.
(01 September 2014)
BRAF, MEK and KIT inhibitors for melanoma: adverse events and their management
Chinese Clinical Oncology
2014;
3
(3)
:29
.
(01 September 2014)
Checkpoint inhibitors in the treatment of cutaneous malignant melanoma
Chinese Clinical Oncology
2014;
3
(3)
:30
.
(01 September 2014)
Toxicity of checkpoint inhibitors
Chinese Clinical Oncology
2014;
3
(3)
:31
.
(01 September 2014)
Algorithm for the management of metastatic cutaneous melanoma
Chinese Clinical Oncology
2014;
3
(3)
:32
.
(01 September 2014)
Adjuvant therapy of mucosal melanoma
Chinese Clinical Oncology
2014;
3
(3)
:33
.
(01 September 2014)
Genotyping of mucosal melanoma
Chinese Clinical Oncology
2014;
3
(3)
:34
.
(01 September 2014)
Treatment of KIT-mutated metastatic mucosal melanoma
Chinese Clinical Oncology
2014;
3
(3)
:35
.
(01 September 2014)
Chemotherapy, biochemotherapy and anti-VEGF therapy in metastatic mucosal melanoma
Chinese Clinical Oncology
2014;
3
(3)
:36
.
(01 September 2014)
Checkpoint inhibitors in treatment of metastatic mucosal melanoma
Chinese Clinical Oncology
2014;
3
(3)
:37
.
(01 September 2014)
Treatment algorithm of metastatic mucosal melanoma
Chinese Clinical Oncology
2014;
3
(3)
:38
.
(01 September 2014)
Statistics in Oncology Clinical Trials2
Biomarker based clinical trial design
Chinese Clinical Oncology
2014;
3
(3)
:39
.
(01 September 2014)
On independent data monitoring committees in oncology clinical trials
Chinese Clinical Oncology
2014;
3
(3)
:40
.
(01 September 2014)
Foreword
What can we do in the journey of fighting cancer?
Chinese Clinical Oncology
2014;
3
(3)
:41
.
(01 September 2014)
Disclosure:
1. The focused issue “Systemic Treatment of Cutaneous and Mucosal Melanoma” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Sanjiv S. Agarwala, Jun Guo and Antonio C. Buzaid served as the unpaid Guest Editors for the focused issue.
2. The series “Statistics in Oncology Clinical Trials” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Daniel J. Sargent and Qian Shi served as the unpaid Guest Editors for the series.
